Search

Balancing and neutralizing heparin dosing after surgeries and hemodialysis treatment is of great importance in medical and clinical fields. In this study, a series of new amphiphilic multi-charged cyclodextrins (AMCD)s as anti-heparin coagulants were designed and synthesized. The AMCD assembly was capable of selective heparin binding through multivalent bonding and showed a better neutralizing effect towards both unfractionated heparin and low molecular weight heparin than protamine in plasma. Meanwhile, an AMCD and vitamin K (VK) co-assembly was prepared to realize heparin-responsive VK release and provide a novel VK deficiency treatment for hemodialysis patients. This AMCD–VK co-assembly for heparin neutralization & vitamin K supplementation synergistic coagulation represents a promising candidate as a clinical anti-heparin coagulant. [ABSTRACT FROM AUTHOR]

A snowflake-like supramolecular clockwise-helical assembly was fabricated via the host–guest interaction of trans-azobenzene-bridged bis(dibenzo-24-crown-8) (trans-1) and a cholesterol derivative, while a snowflake-like supramolecular non-helical assembly can be obtained upon complexation of cis-1 after UV-irradiation, accompanying the disappearance of circular dichroism signals from the azobenzene zone of 1. [ABSTRACT FROM AUTHOR]

A novel supramolecular assembly was constructed by the noncovalent complexation of hexa-cata-hexabenzocoronene modified permethyl-β-cyclodextrins with tetrasodium tetraphenylporphyrintetrasulfonate in water, exhibiting highly efficient excited energy transfer behaviors and a promising DNA photocleavage ability. [ABSTRACT FROM AUTHOR]